Home/Filings/4/0000899243-16-024699
4//SEC Filing

XENOPORT INC 4

Accession 0000899243-16-024699

CIK 0001130591operating

Filed

Jul 5, 8:00 PM ET

Accepted

Jul 6, 9:53 PM ET

Size

25.2 KB

Accession

0000899243-16-024699

Insider Transaction Report

Form 4
Period: 2016-07-05
Harris William G
SVP, Finance and CFO
Transactions
  • Disposition from Tender

    Common Stock

    2016-07-05$7.03/sh159,083$1,118,3530 total
  • Disposition to Issuer

    Stock Options

    2016-07-05$7.03/sh26,000$182,7800 total
    Exercise: $6.38Exp: 2024-02-24Common Stock (26,000 underlying)
  • Disposition to Issuer

    Restricted Stock Units

    2016-07-05$7.03/sh20,000$140,6000 total
    Common Stock (20,000 underlying)
  • Disposition to Issuer

    Restricted Stock Units

    2016-07-05$7.03/sh20,000$140,6000 total
    Common Stock (20,000 underlying)
  • Disposition to Issuer

    Stock Options

    2016-07-05$7.03/sh50,000$351,5000 total
    Exercise: $6.38Exp: 2024-02-24Common Stock (50,000 underlying)
  • Disposition to Issuer

    Stock Options

    2016-07-05$7.03/sh50,000$351,5000 total
    Exercise: $4.90Exp: 2026-01-26Common Stock (50,000 underlying)
  • Disposition to Issuer

    Restricted Stock Units

    2016-07-05$7.03/sh8,500$59,7550 total
    Common Stock (8,500 underlying)
  • Disposition to Issuer

    Stock Options

    2016-07-05$7.03/sh30,000$210,9000 total
    Exercise: $4.34Exp: 2022-01-13Common Stock (30,000 underlying)
  • Disposition to Issuer

    Restricted Stock Units

    2016-07-05$7.03/sh5,000$35,1500 total
    Common Stock (5,000 underlying)
  • Disposition to Issuer

    Restricted Stock Units

    2016-07-05$7.03/sh7,500$52,7250 total
    Common Stock (7,500 underlying)
Footnotes (3)
  • [F1]Pursuant to the terms of the Agreement and Plan of Merger (the "Merger Agreement"), dated May 21, 2016, by and among XenoPort, Inc. ("XenoPort"), Arbor Pharmaceuticals, LLC ("Arbor") and AP Acquisition Sub, Inc. ("AP Acquisition Sub"), a wholly owned subsidiary of Arbor, immediately prior to the Acceptance Time (as defined in the Merger Agreement), each outstanding and unexercised option to purchase shares of common stock of XenoPort was fully vested, cancelled and converted into the right to receive an amount (subject to any applicable withholding tax) in cash equal to: (A) $7.03 per share minus (B) the exercise price per share of common stock of XenoPort.
  • [F2]Each restricted stock unit ("RSU") represents the right to receive one share of common stock of XenoPort.
  • [F3]Pursuant to the terms of the Merger Agreement, immediately prior to the Acceptance Time (as defined in the Merger Agreement), each outstanding RSU was fully vested, cancelled and converted into the right to receive an amount (subject to any applicable withholding tax) in cash equal to $7.03 per share.

Issuer

XENOPORT INC

CIK 0001130591

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001130591

Filing Metadata

Form type
4
Filed
Jul 5, 8:00 PM ET
Accepted
Jul 6, 9:53 PM ET
Size
25.2 KB